Attenuated dopaminergic tone in the paraventricular nucleus contributing to sympathoexcitation in rats with type 2 diabetes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 306, Issue 2, 2014, Pages 138-148

  Zheng, Hong ^a   Liu, Xuefei ^a   Li, Yulong ^a   Mishra, Paras K ^a   Patel, Kaushik P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Central nervous system; Dopaminergic; Sympathetic nerve activity

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ECOPIPAM; RACLOPRIDE; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; HEART RATE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; MEDULLA OBLONGATA; NERVE EXCITABILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROSTRAL VENTROLATERAL MEDULLA; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYMPATHETIC NERVE;

CENTRAL NERVOUS SYSTEM; DOPAMINERGIC; SYMPATHETIC NERVE ACTIVITY;

ANIMALS; BENZAZEPINES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOPAMINE; DOPAMINE ANTAGONISTS; GENE EXPRESSION REGULATION; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84892587481     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00323.2013     Document Type: Article

References (57)

1. Ao Y, Ko M, Chen A, Marvizon JC, Adelson D, Song MK, Go VL, Liu YY, Yang H. Potent hyperglycemic and hyperinsulinemic effects of thyrotropin-releasing hormone microinjected into the rostroventrolateral medulla and abnormal responses in type 2 diabetic rats. Neuroscience 169: 706-719, 2010.
2. Borges GR, de Oliveira M, Salgado HC, Fazan R Jr. Myocardial performance in conscious streptozotocin diabetic rats. Cardiovasc Diabe-tol 5: 26, 2006.
3. Card JP, Sved JC, Craig B, Raizada M, Vazquez J, Sved AF. Efferent projections of rat rostroventrolateral medulla C1 catecholamine neurons: Implications for the central control of cardiovascular regulation. J Comp Neurol 499: 840-859, 2006.
4. Dampney RA. The subretrofacial vasomotor nucleus: Anatomical, chemical and pharmacological properties and role in cardiovascular regulation. Prog Neurobiol 42: 197-227, 1994.
5. Dearry A, Gingrich JA, Palardeai P, Fremeau RT Jr, Bates MD, Caron MG. Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347: 72-76, 1990.
6. Fachinetto R, Burger ME, Wagner C, Wondracek DC, Brito VB, Nogueira CW, Ferreira J, Rocha JB. High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats. Phamacol Biochem Behav 81: 585-592, 2005.
7. Gladwell SJ, Pyner S, Barnes NM, Coote JH. D1-like dopamine receptors on retrogradely labelled sympathoadrenal neurones in the thoracic spinal cord of the rat. Exp Brain Res 128: 377-382, 1999
8. Hatcher JM, Richardson JR, Guillot TS, OcCormack AL, Di Monte DA, Jones DP, Pennell KD, Miller GW. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol 204: 619-630, 2007.
9. Horie S, Shioda S, Nakai Y. Catecholaminergic innervation of oxytocin neurons in the paraventricular nucleus of the rat hypothalamus as revealed by double-labeling immunoelectron microscopy. Ada Anat (Basel) 147: 184-192, 1993.
10. Howe BM, Bruno SB, Higgs KA, Stigers RL, Cunningham JT. FosB expression in the central nervous system following isotonic volume expansion in unanesthetized rats. Exp Neurol 187: 190-198, 2004.
11. Huggett RJ, Scott EM, Gilbey SG, Stocker JB, Mackintosh AF, Mary DA. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 108: 3097-3101, 2003.
12. Hyde TM, Knable MB, Murray AM. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse 24: 224-232, 1996.
13. Jansen ASP, Wessendorf MW, Loewy AD. Transneuronal labeling of CNS neuropeptide and monoamine neurons after pseudorabies virus injections into the stellate ganglion. Brain Res 683: 1-24, 1995.
14. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol 294: R1863-R1872, 2008.
15. Knight WD, Little JT, Carreno FR, Toney GM, Mifflin SW, Cunningham JT. Chronic intermittent hypoxia increases blood pressure and expression of FosB/DeltaFosB in central autonomic regions. Am J Physiol Regul Integr Comp Physiol 301: R131-R139, 2011.
16. Kondo K, Matsubara T, Nakamura J, Hotta N. Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in Type 2 diabetic patients. Diabet Med 19: 359-365, 2002.
17. Krukoff TL, Patel KP. Alterations in brain hexokinase activity associated with streptozotocin-induced diabetic mellitus in the rat. Brain Res 522: 157-160, 1990.
18. Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol 8: 405-416, 2012.
19. Kusakabe T, Tanioka H, Ebihara K, Kirata M, Miyamoto L, Mi-yanaga F, Hige H, Aotani D, Fujisawa T, Masuzaki H, Hosoda K, Nakao K. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia 52: 675-683, 2009.
20. Kuzhikandathil EV, Oxford GS. Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels. Mol Pharmacol 62: 119-126, 2002.
21. Liposits Z, Paull WK. Association of dopaminergic fibers with cortico-tropin releasing hormone (CRH)-synthesizing neurons in the paraventricular nucleus of the rat hypothalamus. Histochemistry 93: 119-127, 1989.
22. Liu J, Tu H, Zheng H, Zhang L, Tran TP, Muelleman RL, Li YL. Alterations of calcium channels and cell excitability in intracardiac ganglion neurons from type 2 diabetic rats. Am J Physiol Cell Physiol 302: C1119-C1127, 2012.
23. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr Diabetes Rev 6: 58-67, 2010.
24. Melis MR, Argiolas A, Gessa GL. Apomorphine-induced penile erection and yawning: site of action in brain. Brain Res 415: 98-104, 1987.
25. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci 90: 189-195, 1996.
26. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 78: 189-225, 1998.
27. Morris JK, Bomhoff GL, Gorres BK, Davis VA, Kim J, Lee PP, Brooks WM, Gerhardt GA, Geiger PC, Stanford JA. Insulin resistance impairs nigrostriatal dopamine function. Exp Neurol 231: 171-180, 2011.
28. Morrison CD, Pistell PJ, Ingram DK, Johnson WD, Liu Y, Fernandez-Kim SO, White CL, Purpera MN, Uranga RM, Bruce-Keller AJ. High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J Neuro-chem 114: 1581-1589, 2010.
29. Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes 55: 1695-1704, 2006.
30. Murphy MB. Dopamine: a role in the pathogenesis and treatment of hypertension. J Hum Hypertens 14 Suppl: S47-S50, 2000.
31. Palkovits M, Brownstein M. Brain microdissection techniques. In: Brain Microdissection Techniques, edited by Cuello AE. Chichester, UK: John Wiley, 1983.
32. Parker M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248-254, 1992.
33. Pascoe WS, Storlien LH. Inducement by fat feeding of basal hypergly-cemia in rats with abnormal fj-cell function. Model for study of etiology and pathogenesis of NIDDM. Diabetes 39: 226-233, 1990.
34. Patel KP, Knuepfer M. Effect of afferent renal nerve stimulation on blood pressure and heart rate and noradrenergic activity in conscious rats. J Auton Nerv Syst 17: 121-130, 1986.
35. Patel KP, Mayhan WG, Bidasee KR, Zheng H. Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion. Am J Physiol Regul Integr Comp Physiol 300: R311-R320, 2011.
36. Patel KP, Zhang PL. Baroreflex function in streptozotocin (STZ)-in-duced diabetic rats. Diabetes Res Clin Pract 27: 1-9, 1995.
37. Pellegrino LJ, Cushman AJ. A Stereotaxic Atlas of the Rat Brain. New York: Appleton-Century-Crofts, 1967.
38. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome? Eur J Pharmacol 480: 125-131, 2003.
39. Prior LJ, Elkelis N, Armitage JA, Davern PJ, Burke SL, Montani JP, Barzel B, Head GA. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55: 862-868, 2010.
40. Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: Implications for cardiovascular regulation. J Chem Neuroanat 38: 197-208, 2009.
41. Rahmouni K, Haynes WG. Leptin and the central neural mechanisms of obesity hypertension. Drugs Today (Bare) 38: 807-817, 2002.
42. Rahmouni K, Sigmund CD, Haynes WG, Mark AL. Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58: 536-542, 2009.
43. Schreihofer AM, Stornetta RL, Guyenet PG. Regulation of sympathetic tone and arterial pressure by rostral ventrolateral medulla after depletion of C1 cells in rat. J Physiol 529: 221-236, 2000.
44. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 341: 577-585, 1999.
45. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26: 327-333, 2004.
46. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 125: 451-472, 2007.
47. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol Endocrinol Metab 251: E576-E583, 1986.
48. Strack AM Sawyer WB, Platt KB, Loewy AD. CNS cell groups regulating the sympathetic outflow to the adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 491: 274-296, 1989.
49. Swanson LW, Sawchenko PE, Berod A, Hartman BK, Helle KB, Vanorden DE. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus. J Comp Neurol 196: 271-285, 1981.
50. Vahid-Ansari F, Leenen FHH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol 275: H2140-H2146, 1998.
51. Wamsley JK, Hunt ME, McQuade RD, Alburges ME. [3H]SCH39166, a D1 dopamine receptor antagonist: binding characteristics and localization. Exp Neurol 111: 145-151, 1991.
52. Wang Y, Patel KP, Cornish KG, Channon KM, Zucker IH. nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 285: H1660-H1667, 2003.
53. Ward KR, Bardgett JF, Wolfgang L, Stocker SD. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 57: 435-441, 2011.
54. Yang Z, Wheatley M, Coote JH. Neuropeptides, amines and amino acids as mediators of the sympathetic effects of paraventricular nucleus activation in the rat. Exp Physiol 87: 663-674, 2002.
55. Zhang PL, Patel KP. Blunted diuretic and natriuretic responses to central administration of clonidine in streptozocin-induced diabetic rats. Diabetes 40: 338-343, 1991.
56. Zheng H, Mayhan WG, Bidasee KR, Patel KP. Blunted nitric oxide-mediated inhibition of sympathetic nerve activity within the paraventricu-lar nucleus in diabetic rats. Am J Physiol Regul Integr Comp Physiol 290: R992-R1002, 2006.
57. Zheng H, Sharma NM, Liu X, Patel KP. Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II. Am J Physiol Regul Integr Comp Physiol 303: R387-R394, 2012.